APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti Asthma Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti Asthma Drugs Industry Growth and Trends Forecast to 2032

19 December 202599 pages

Choose your research edition.

Industry ResearchAnti Asthma Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti Asthma Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Anti Asthma Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti Asthma Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti Asthma Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Anti Asthma Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti Asthma Drugs include Boehringer Ingelheim, F. Hoffmann-La Roche, Sunovion Pharmaceuticals, Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline, Merck & Co and Novartis International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti Asthma Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti Asthma Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti Asthma Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti Asthma Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti Asthma Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti Asthma Drugs Market by Company

Boehringer Ingelheim

F. Hoffmann-La Roche

Sunovion Pharmaceuticals

Teva Pharmaceutical

AstraZeneca

GlaxoSmithKline

Merck & Co

Novartis International

Anti Asthma Drugs Segment by Type

Bronchodilators

Corticosteroids

Mast Cell Stabilizers

Monoclonal Antibody

Leukotriene Antagonists

Anti Asthma Drugs Segment by Application

Clinics

Hospitals

Other

Anti Asthma Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti Asthma Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti Asthma Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti Asthma Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti Asthma Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti Asthma Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Bronchodilators Table 2. Major Company of Corticosteroids Table 3. Major Company of Mast Cell Stabilizers Table 4. Major Company of Monoclonal Antibody Table 5. Major Company of Leukotriene Antagonists Table 6. Global Anti Asthma Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Anti Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 8. Global Anti Asthma Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Anti Asthma Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Anti Asthma Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Anti Asthma Drugs Price by Type (2021-2026) & (US$/Unit) Table 12. Global Anti Asthma Drugs Sales by Type (2027-2032) & (K Units) Table 13. Global Anti Asthma Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Anti Asthma Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Anti Asthma Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Anti Asthma Drugs Price by Type (2027-2032) & (US$/Unit) Table 17. North America Anti Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 18. North America Anti Asthma Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Anti Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 20. Europe Anti Asthma Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Anti Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Anti Asthma Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Anti Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 24. Latin America Anti Asthma Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Anti Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Anti Asthma Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Anti Asthma Drugs Industry Trends Table 28. Anti Asthma Drugs Industry Drivers Table 29. Anti Asthma Drugs Industry Opportunities and Challenges Table 30. Anti Asthma Drugs Industry Restraints Table 31. Global Anti Asthma Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Anti Asthma Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Anti Asthma Drugs Sales by Company (2021-2026) & (K Units) Table 34. Global Anti Asthma Drugs Sales Share by Company (2021-2026) Table 35. Global Anti Asthma Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Anti Asthma Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Anti Asthma Drugs Major Company Production Sites and Headquarters Table 38. Global Anti Asthma Drugs Company, Product Type & Application Table 39. Global Anti Asthma Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Anti Asthma Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Anti Asthma Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Anti Asthma Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Anti Asthma Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Anti Asthma Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Anti Asthma Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Anti Asthma Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Anti Asthma Drugs Sales by Region (2027-2032) & (K Units) Table 49. Global Anti Asthma Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Anti Asthma Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Anti Asthma Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Anti Asthma Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Anti Asthma Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Anti Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 55. Global Anti Asthma Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Anti Asthma Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Anti Asthma Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Anti Asthma Drugs Price by Application (2021-2026) & (US$/Unit) Table 59. Global Anti Asthma Drugs Sales by Application (2027-2032) & (K Units) Table 60. Global Anti Asthma Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Anti Asthma Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Anti Asthma Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Anti Asthma Drugs Price by Application (2027-2032) & (US$/Unit) Table 64. North America Anti Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 65. North America Anti Asthma Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Anti Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 67. Europe Anti Asthma Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Anti Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Anti Asthma Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Anti Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 71. Latin America Anti Asthma Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Anti Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Anti Asthma Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Boehringer Ingelheim Company Information Table 75. Boehringer Ingelheim Business Overview Table 76. Boehringer Ingelheim Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Boehringer Ingelheim Anti Asthma Drugs Product Portfolio Table 78. Boehringer Ingelheim Recent Development Table 79. F. Hoffmann-La Roche Company Information Table 80. F. Hoffmann-La Roche Business Overview Table 81. F. Hoffmann-La Roche Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. F. Hoffmann-La Roche Anti Asthma Drugs Product Portfolio Table 83. F. Hoffmann-La Roche Recent Development Table 84. Sunovion Pharmaceuticals Company Information Table 85. Sunovion Pharmaceuticals Business Overview Table 86. Sunovion Pharmaceuticals Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sunovion Pharmaceuticals Anti Asthma Drugs Product Portfolio Table 88. Sunovion Pharmaceuticals Recent Development Table 89. Teva Pharmaceutical Company Information Table 90. Teva Pharmaceutical Business Overview Table 91. Teva Pharmaceutical Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Teva Pharmaceutical Anti Asthma Drugs Product Portfolio Table 93. Teva Pharmaceutical Recent Development Table 94. AstraZeneca Company Information Table 95. AstraZeneca Business Overview Table 96. AstraZeneca Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. AstraZeneca Anti Asthma Drugs Product Portfolio Table 98. AstraZeneca Recent Development Table 99. GlaxoSmithKline Company Information Table 100. GlaxoSmithKline Business Overview Table 101. GlaxoSmithKline Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. GlaxoSmithKline Anti Asthma Drugs Product Portfolio Table 103. GlaxoSmithKline Recent Development Table 104. Merck & Co Company Information Table 105. Merck & Co Business Overview Table 106. Merck & Co Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Merck & Co Anti Asthma Drugs Product Portfolio Table 108. Merck & Co Recent Development Table 109. Novartis International Company Information Table 110. Novartis International Business Overview Table 111. Novartis International Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Novartis International Anti Asthma Drugs Product Portfolio Table 113. Novartis International Recent Development Table 114. North America Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. North America Anti Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 116. North America Anti Asthma Drugs Sales Market Share by Country (2021-2026) Table 117. North America Anti Asthma Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 118. North America Anti Asthma Drugs Sales Market Share Forecast by Country (2027-2032) Table 119. North America Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. North America Anti Asthma Drugs Market Size by Country (2021-2026) & (US$ Million) Table 121. North America Anti Asthma Drugs Market Share by Country (2021-2026) Table 122. North America Anti Asthma Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. North America Anti Asthma Drugs Market Share Forecast by Country (2027-2032) Table 124. Europe Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Europe Anti Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 126. Europe Anti Asthma Drugs Sales Market Share by Country (2021-2026) Table 127. Europe Anti Asthma Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 128. Europe Anti Asthma Drugs Sales Market Share Forecast by Country (2027-2032) Table 129. Europe Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Europe Anti Asthma Drugs Market Size by Country (2021-2026) & (US$ Million) Table 131. Europe Anti Asthma Drugs Market Share by Country (2021-2026) Table 132. Europe Anti Asthma Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Europe Anti Asthma Drugs Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Anti Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 136. Asia-Pacific Anti Asthma Drugs Sales Market Share by Country (2021-2026) Table 137. Asia-Pacific Anti Asthma Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 138. Asia-Pacific Anti Asthma Drugs Sales Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Anti Asthma Drugs Market Size by Country (2021-2026) & (US$ Million) Table 141. Asia-Pacific Anti Asthma Drugs Market Share by Country (2021-2026) Table 142. Asia-Pacific Anti Asthma Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Asia-Pacific Anti Asthma Drugs Market Share Forecast by Country (2027-2032) Table 144. Latin America Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. Latin America Anti Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 146. Latin America Anti Asthma Drugs Sales Market Share by Country (2021-2026) Table 147. Latin America Anti Asthma Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 148. Latin America Anti Asthma Drugs Sales Market Share Forecast by Country (2027-2032) Table 149. Latin America Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Latin America Anti Asthma Drugs Market Size by Country (2021-2026) & (US$ Million) Table 151. Latin America Anti Asthma Drugs Market Share by Country (2021-2026) Table 152. Latin America Anti Asthma Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Latin America Anti Asthma Drugs Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Anti Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 156. Middle East and Africa Anti Asthma Drugs Sales Market Share by Country (2021-2026) Table 157. Middle East and Africa Anti Asthma Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 158. Middle East and Africa Anti Asthma Drugs Sales Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Anti Asthma Drugs Market Size by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Anti Asthma Drugs Market Share by Country (2021-2026) Table 162. Middle East and Africa Anti Asthma Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Middle East and Africa Anti Asthma Drugs Market Share Forecast by Country (2027-2032) Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Anti Asthma Drugs Distributors List Table 167. Anti Asthma Drugs Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Anti Asthma Drugs Image Figure 2. Global Anti Asthma Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti Asthma Drugs Sales (2021-2032) & (K Units) Figure 5. Bronchodilators Image Figure 6. Global Bronchodilators Sales YoY Growth (2021-2032) & (K Units) Figure 7. Corticosteroids Image Figure 8. Global Corticosteroids Sales YoY Growth (2021-2032) & (K Units) Figure 9. Mast Cell Stabilizers Image Figure 10. Global Mast Cell Stabilizers Sales YoY Growth (2021-2032) & (K Units) Figure 11. Monoclonal Antibody Image Figure 12. Global Monoclonal Antibody Sales YoY Growth (2021-2032) & (K Units) Figure 13. Leukotriene Antagonists Image Figure 14. Global Leukotriene Antagonists Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Anti Asthma Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Anti Asthma Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Anti Asthma Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Anti Asthma Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Anti Asthma Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Anti Asthma Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Anti Asthma Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Anti Asthma Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Anti Asthma Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Anti Asthma Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Anti Asthma Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Anti Asthma Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Anti Asthma Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinics Image Figure 30. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hospitals Image Figure 32. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Anti Asthma Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Anti Asthma Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Anti Asthma Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Anti Asthma Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Anti Asthma Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Anti Asthma Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Anti Asthma Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Anti Asthma Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Anti Asthma Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Anti Asthma Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Anti Asthma Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Anti Asthma Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Anti Asthma Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Anti Asthma Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Anti Asthma Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Anti Asthma Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Anti Asthma Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Anti Asthma Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Anti Asthma Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Anti Asthma Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Anti Asthma Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Anti Asthma Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Anti Asthma Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Anti Asthma Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Anti Asthma Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Anti Asthma Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Anti Asthma Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Anti Asthma Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Anti Asthma Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Anti Asthma Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Anti Asthma Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Anti Asthma Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Anti Asthma Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Anti Asthma Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Bronchodilators
  • Corticosteroids
  • Mast Cell Stabilizers
  • Monoclonal Antibody
  • Leukotriene Antagonists
Applications
  • Clinics
  • Hospitals
  • Other
Companies covered
  • Boehringer Ingelheim
  • F. Hoffmann-La Roche
  • Sunovion Pharmaceuticals
  • Teva Pharmaceutical
  • AstraZeneca
  • GlaxoSmithKline
  • Merck & Co
  • Novartis International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti Asthma Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti Asthma Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti Asthma Drugs Market by Type
  6. 1.3.1 Bronchodilators
  7. 1.3.2 Corticosteroids
  8. 1.3.3 Mast Cell Stabilizers
  9. 1.3.4 Monoclonal Antibody
  10. 1.3.5 Leukotriene Antagonists
  11. 1.4 Global Anti Asthma Drugs Market Size by Type
  12. 1.4.1 Global Anti Asthma Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Anti Asthma Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Anti Asthma Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Anti Asthma Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Anti Asthma Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Anti Asthma Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Anti Asthma Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Anti Asthma Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti Asthma Drugs Industry Trends
  2. 2.2 Anti Asthma Drugs Industry Drivers
  3. 2.3 Anti Asthma Drugs Industry Opportunities and Challenges
  4. 2.4 Anti Asthma Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti Asthma Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti Asthma Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Anti Asthma Drugs Price (2021-2026)
  4. 3.4 Global Anti Asthma Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti Asthma Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Anti Asthma Drugs Company, Product Type & Application
  7. 3.7 Global Anti Asthma Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti Asthma Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti Asthma Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti Asthma Drugs Tier 1, Tier 2, and Tier 3
4 Anti Asthma Drugs Regional Status and Outlook
  1. 4.1 Global Anti Asthma Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti Asthma Drugs Historic Market Size by Region
  3. 4.2.1 Global Anti Asthma Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti Asthma Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti Asthma Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti Asthma Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Anti Asthma Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti Asthma Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti Asthma Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti Asthma Drugs by Application
  1. 5.1 Anti Asthma Drugs Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Other
  5. 5.2 Global Anti Asthma Drugs Market Size by Application
  6. 5.2.1 Global Anti Asthma Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Anti Asthma Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Anti Asthma Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Anti Asthma Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Anti Asthma Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Anti Asthma Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Anti Asthma Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Anti Asthma Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Anti Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Anti Asthma Drugs Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 F. Hoffmann-La Roche
  8. 6.2.1 F. Hoffmann-La Roche Company Information
  9. 6.2.2 F. Hoffmann-La Roche Business Overview
  10. 6.2.3 F. Hoffmann-La Roche Anti Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 F. Hoffmann-La Roche Anti Asthma Drugs Product Portfolio
  12. 6.2.5 F. Hoffmann-La Roche Recent Developments
  13. 6.3 Sunovion Pharmaceuticals
  14. 6.3.1 Sunovion Pharmaceuticals Company Information
  15. 6.3.2 Sunovion Pharmaceuticals Business Overview
  16. 6.3.3 Sunovion Pharmaceuticals Anti Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sunovion Pharmaceuticals Anti Asthma Drugs Product Portfolio
  18. 6.3.5 Sunovion Pharmaceuticals Recent Developments
  19. 6.4 Teva Pharmaceutical
  20. 6.4.1 Teva Pharmaceutical Company Information
  21. 6.4.2 Teva Pharmaceutical Business Overview
  22. 6.4.3 Teva Pharmaceutical Anti Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Teva Pharmaceutical Anti Asthma Drugs Product Portfolio
  24. 6.4.5 Teva Pharmaceutical Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Anti Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Anti Asthma Drugs Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Anti Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Anti Asthma Drugs Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 Merck & Co
  38. 6.7.1 Merck & Co Company Information
  39. 6.7.2 Merck & Co Business Overview
  40. 6.7.3 Merck & Co Anti Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck & Co Anti Asthma Drugs Product Portfolio
  42. 6.7.5 Merck & Co Recent Developments
  43. 6.8 Novartis International
  44. 6.8.1 Novartis International Company Information
  45. 6.8.2 Novartis International Business Overview
  46. 6.8.3 Novartis International Anti Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Novartis International Anti Asthma Drugs Product Portfolio
  48. 6.8.5 Novartis International Recent Developments
7 North America by Country
  1. 7.1 North America Anti Asthma Drugs Sales by Country
  2. 7.1.1 North America Anti Asthma Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti Asthma Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Anti Asthma Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti Asthma Drugs Market Size by Country
  6. 7.2.1 North America Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti Asthma Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti Asthma Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti Asthma Drugs Sales by Country
  2. 8.1.1 Europe Anti Asthma Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti Asthma Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti Asthma Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti Asthma Drugs Market Size by Country
  6. 8.2.1 Europe Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti Asthma Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti Asthma Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti Asthma Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Anti Asthma Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti Asthma Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti Asthma Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti Asthma Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti Asthma Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti Asthma Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti Asthma Drugs Sales by Country
  2. 10.1.1 South America Anti Asthma Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti Asthma Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Anti Asthma Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti Asthma Drugs Market Size by Country
  6. 10.2.1 South America Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti Asthma Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti Asthma Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti Asthma Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Anti Asthma Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti Asthma Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti Asthma Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti Asthma Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti Asthma Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti Asthma Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti Asthma Drugs Value Chain Analysis
  2. 12.1.1 Anti Asthma Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti Asthma Drugs Production Mode & Process
  7. 12.2 Anti Asthma Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti Asthma Drugs Distributors
  10. 12.2.3 Anti Asthma Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst